Dr. Michael Thompson

Hematology and Oncology
Milwaukee, WI
22 years experience male

About

Bio

I am passionate about clinical trials, translational and basic science research. It is a tragedy that only 2-7% of adults participate in cancer clinical trials (Zon R. et al. ASCO statement on minimum standards and exemplary attributes of clinical trial sites. J Clin Oncol. 2008) Improved clinical trial enrollment depends on well designed, interesting trials, informed patients that may even assist in clinical trial design, institutional infrastructure support, as well as local and national leadership and coordination. The treatment standards of care we have today in oncology are built upon the clinical trial leadership and patient participation of the past. Clinical trials benefit the individual and society and should be encouraged in the community setting. My goal is to offer patients the best therapy available for their individual situation. My PhD research was in pharmacogenetics. That is the study of how heredity changes one’s response to drugs (such as chemotherapy). I believe that this same personalized approach to drug research also applies to how I care for patients. Everyone is an individual. I am interested in cancer and hematologic or blood cancers (lymphoma, myeloma, leukemia, and myelodysplastic syndrome (MDS). I am also interested in developing new treatments for all cancers, particularly early phase molecular biomarker driven studies. I believe that we live in an exciting era in which new drugs are providing options for improving quality of life and survival.

Specialties
Doctors may have more than one area of specialty interest. Board certification in a specialty area means the doctor has completed formal training and has practice experience in that specialty, and has passed the certification examination from the corresponding accredited medical specialty board.

Hematology and Oncology

Hematology

Internal Medicine

Medical Oncology

Doctor Q&A

527 Answers
847 Agrees
The number of answers this doctor has agreed with.
A 27-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
CLL: Cll is a clonal disorder (cancer) of the white blood cells (specifically lymphocytes) in the blood (= -emia part). Other leukemias include cml, aml, a... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 18-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
No: One can have many varieties of cancer including lymphoma with a normal complete blood count (CBC) and comprehensive metabolic panel (cmp).
Created for people with ongoing healthcare needs but benefits everyone.
A 18-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Soft, non-fixed: Normal lymph nodes may vary somewhat, but in general normal is non-fixed (movable), soft (not firm). Size < 1-2 cm. Enlarged lymph nodes may be a non-... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Oncologist: Several. Hematologist/oncologist, gyn onc, neuro onc. And depending on definition of "chemo" -- urology, rheumatology, nephrology, etc. That is, many ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Common: Most common cause is infection. Not all lymphadenopathy is cancer.
Created for people with ongoing healthcare needs but benefits everyone.
A 36-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Varies: The "family history" of colon cancer needs to be further clarified as to what type of family syndrome this is. A genetic counselor can help further d... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 31-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Talk: I think the most important thing to do is talk. Don't assume she knows what is going on exactly or how she feels. In many locations there are special ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 54-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Many new options: Therapy for myeloma has evolved from cytotoxic drugs (mp, vad, hcvad) to the immunomodulatory drug (imid) thalidomide. More recent drugs include the i... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 47-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Depends: First, different chemotherapies are associated with different rates of alopecia (hair loss). A common breast cancer regimen -- AC (adriamycin, cycloph... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Tobacco, alcohol: 2 types of esophageal ca - scc, adca. Geographic location - high risk = asia, s & e africa, n. France. Scc - tobacco, alcohol, gerd, barrett's esophag... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
1-2-3: Cancer 1-2-3: 1) diagnosis - myeloma vs. ? 2a) stage - iss (not that relevant for individual) 2b) prognostic factors - eg cytogenetics, pcli (if avail... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 41-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Research: Pancreas cancer is a tough cancer to cure. Recent treatments in addition to gemcitabine include abraxane, tarceva, (erlotinib) and a tough regimen cal... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Which cancer?: Adjuvant (post surgery) treatment does have an end. Some metastatic treatments usually end at a maximum number of cycles of therapy (eg lung cancer - ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
"Many": Myeloma and other plasma cell dyscrasia treatments has evolved from standard cytotoxic approaches (eg mp, vad, hypercvad) to "novel" therapies. Immuno... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Location: Avms may be located in the brain (as 1st answer noted) or in the "gut" (gastrointestinal tract). The location, size, and severity help determine the c... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Find a Hematologist: American society of hematology (ash) "find a hematologist" website: http://store.Hematology.Org/default.Aspx?Tabid=231 or 1) mmrf, lls, or other adv... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
It depends...: Treatment options for mm are plentiful and are dependent on: patient characteristics (age, comorbidities -- diabetes, neuropathy, cv disease, etc), mm... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 16-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes/No: In a sense all cancer is "genetic" involving changes to the DNA or epi-genetic - changes to DNA modifiers such as methylation. A related question is i... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
It depends...: Nhl has over 40 subtypes. Treatment depends on dx, stage, prognosis, tumor & patient factors. Dlbcl: r-chop most common fl: observation vs. Rituximab ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Depends: Depends on subtype of lymphoma (over 40 subtypes), stage, prognostic factors, etc.
Created for people with ongoing healthcare needs but benefits everyone.
A 22-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes/It depends: Everyone is a potential candidate for clinical trials. Historically inclusion/exclusion (i/e) criteria have selected only the healthiest people. Incre... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 21-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
BMB + labs: Myeloma can be suspected by "crab" symptoms including abnormalities found on x-rays or other imaging studies and laboratory studies. A definitive diag... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 41-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Maybe: Bleeding should be evaluated. It may be something such as ulcers in the stomach or hemorrhoids. However, bleeding could be a sign of colon cancer. Thi... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 31-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Possible: In a sense all cancer is "genetic" in that it occurs do to changes in dna that cause cancer formation. However, if your questions is about familial/i... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 36-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Variable: The effect of adjuvant (post surgical) therapy (chemotherapy, endocrine therapy, etc) is variable. For some early cancers such as stage ii colon canc... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 27-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Maybe - adjuvant: Pancreas cancer is basically divided into 1) resectable (by surgery) 2) borderline resectable 3) metastatic (spread distantly). Radiation may be used ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 41-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Support Net: Build/maintain your support net. That is inclusive of friends family as well as cancer staff such as your md, nurse, counselors, etc. Patient navigato... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 31-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Depends on Dx: It depends on your leukemia diagnosis. There are many types of leukemia including cll, cml, all, AML with wide variability in the treatment approaches... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 34-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Extranodal lymphoma: Lymphoma in the lungs may be in the lymph nodes (nodal) or in the lung parenchyma (lung tissue itself = extranodal = outside of lymph nodes). While t... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 35-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Potentially: Brca tx may include chemo, hormones, radiation, bone targeted tx & diet/exercise as "adjvuant" (post surgery) treatment. The combo needed depends on t... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 34-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Skin color: Usually lipomas are small (sub-cm) to large (several cm) rubbery benign (non-cancerous) fat tumors. They are usually located in the subcutaneous tissu... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 27-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes: Melanoma can occur in sun exposed areas. However, it can (and does) occur in areas where "the sun doesn't shine". Additionally, melanoma may be amela... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 37-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Treat tumor: Para = associated with neoplastic = cancer some symptoms may be treated (such as high calcium), but the primary cause -- that is, the tumor -- needs ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 27-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes: Often a bone marrow biopsy is needed to fully characterize a leukemia, but leukemia may be noted in the peripheral blood when it is smeared on a glass... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 25-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Lymphoma vs. other: The spleen in hl may be heterogeneous/inhomogeneous/non-uniform due to lymphoma involvement, spleen infarction (death) due to cancer death in the sple... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 33-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
No: Lung "tumors" may be benign or malignant (=cancer). Cancers in the lung may be primary lung cancer (eg, small cell or non-small cell lung cancer, meso... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 35-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
DVT, varicose, etc: Painful veins could be many things including: varicose veins, blood clot (superficial or deep -- dvt), thrombophlebitis (inflammation/infection of the... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 41-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Depends: A CBC - complete blood count - has many values. 3 cell types are white blood cells (wbcs), red blood cells (rbc, but measured as hemoglobin - hgb), an... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 24-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes: Rectal cancer, like any cancer needs - 1) diagnosis, 2) staging and prognosis, 3) treatment. Early rectal cancer may be treated by surgery alone. More... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 27-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
I don't know: Melanoma and lymphoma are two separate tumors. Maybe you are seeing a typo or potentially a differential diagnosis and the confirmed diagnosis isn't c... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 41-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Not likely: Nose bleeds (epistaxis) can be caused by many things including picking (#1), vascular problems, blood problems. Kidney cancer would not be anywhere on... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 38-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Varies. ~10yrs: In general, we think about 10 years. Hence the "standard" colon screening recommendation (by colonoscopy) of every 10 years if the colon is well prepp... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 38-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
CA 125 - Why check?: 8.6 sounds like a normal value for the cancer antigen 125 (ca125) laboratory test. However, why did you want to get it? It is not a screening test fo... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 37-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes: Since the uterus is still present, cancer can develop in it. Additionally, even with ovaries removed, there are sometimes ovarian cells present that m... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 38-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Reframe question: I would re-frame the question as -- @hat are effective therapies for uterine cancer? Alternative to what? Whatever the therapy utilized, one must ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 29-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Theoretical: Theoretically immune-based therapy such as vaccines may have advantages of "conventional" cytotoxic chemotherapies. Until recently, most immunotherapi... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 53-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
No: No. Often sk's appear/increase as people age.
Created for people with ongoing healthcare needs but benefits everyone.
A 50-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Symptoms and imaging: People usually present with symptoms -- eg, fever, chills, night sweats, fatigue, lymph node enlargement, spleen enlargement, etc. Then (or sometimes ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
50%, 90%, 100%: Confirmation of response in wm has been adopted from response criteria for multiple myeloma. See http://www.Iwmf.Com/docs/ghobrial_clincial_trials.Pdf ... Read More
Created for people with ongoing healthcare needs but benefits everyone.
A 33-year-old member asked:
Dr. Michael Thompson
Hematology and Oncology 22 years experience
Yes: Cancer is common. Lifetime risks: 1 in 3 for women & 1 in 2 for men of developing cancer. That said, cancer is not an even distribution in the populat... Read More
Created for people with ongoing healthcare needs but benefits everyone.

Testimonials
Recommendations and Thank you notes are endorsements given from patients or other doctors.

18
Recommendations
727
Thank you notes
Mar 19, 2015
Hi Doc: Great virtual practice!! Louis Gallia MD, DMD, FACS
Aug 26, 2013
Good Knowledgeable answers and Caring Approach
Aug 26, 2013
Good Knowledgeable answers and Caring Approach
HealthTap member
I'm very thankful to have received a responce. Not able to pay at th is moment to send complete. Info. Will contact back ASAP hopeful. Txs.
HealthTap member
Thank U 4 Ur help, I have elevated creatinine, B12 monthly injections and still tired. Been on, methotrexate b4 4 suspected RA, results neg
HealthTap member
Thank you. I am being treated for lgl. Was diagnosed 7 1/2 yes ago. Was just wondering about an new and safer advancements in treatments. Ty

Education & Training

Medical/Graduate school

Mayo Clinic College of Medicine
Graduated 2001MD

Medical/Graduate school

Mayo Clinic College of Medicine
Graduated 2001MD

Medical/Graduate school

University of Wisconsin, Madison
Graduated 1993MD

Medical/Graduate school

Mayo Clinic College of Medicine, MN
Graduated 2001MD

Residency

Mayo Health System

Residency

Internal Medicine

Awards

Academy for Health Science Education (ASHE) Developer Grant, MD Anderson Cancer Center
NCI Community Cancer Centers Program (NCCCP), NCI
Young Investigator Award (YIA), ASCO

Affiliations

American Society of Hematology
American Society of Clinical Oncology
American Society of Clinical Oncology, Integrated Technology Committee

Publications

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlle...
CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.
90,000 U.S. doctors in 147 specialties are here to answer your questions, provide medical advice, write prescriptions, and more.
Answer emailed
in 24 hours or less